The Novartis Venture Fund, based in Cambridge, MA, is dedicated to fostering innovation in life science investment to benefit patients worldwide. With over USD 750 million in committed capital, the fund invests in a diverse range of biotechnology and biopharmaceutical companies at various stages of growth and development.
Through a hands-on approach, the Novartis Venture Fund team, with expertise in drug discovery and development, collaborates closely with portfolio companies to drive real clinical impact. Their focus on novel therapeutics and platforms aims to address unmet patient needs across the healthcare spectrum, reflecting a commitment to advancing the future of global healthcare.
Generated from the website